Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program.

Source:http://linkedlifedata.com/resource/pubmed/id/10087434

Download in:

View as

General Info

PMID
10087434